Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis

Journal of Endocrinological Investigation

Volumn 26, Issue 8, 2003, Pages 733-737

  Nascif, S O ^a   Senger, M H ^b   Ramos Dias, J C ^b   Lengyel, Ana M J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Ciencias Medicas   (Brazil)

Author keywords

GHRH; GHRP 6; Iopanoic acid; Thyrotoxicosis

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR[1-29]; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; IOPANOIC ACID; LIOTHYRONINE; PROPYLTHIOURACIL; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GRAVES DISEASE; HORMONE RESPONSE; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; SHORT COURSE THERAPY; THYROTOXICOSIS;

EID: 0344013165     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347355     Document Type: Article

References (41)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656-60.
2. Dieguez C, Food SM, Peters JR, Hall R, Scanlon MF. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells. Endocrinology 1985, 116: 1066-70.
3. Jones PM, Burrin JM, Ghatei MA, O'Halloran DJ, Legon S, Bloom SR. The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. Endocrinology 1990, 126: 1374-9.
4. Valcavi R, Zini M, Portioli I. Thyroid hormones and growth hormone secretion. J Endocrinol Invest 1992, 15: 313-30.
5. Giustina A, Wehrenberg WB. Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol 1995, 133: 646-53.
6. Yaffe BM, Samuels HH. Hormonal regulation of the growth hormone gene. J Biol Chem 1984, 259: 6284-91.
7. Diamond DJ, Goodman HM. Regulation of growth hormone messenger RNA synthesis by dexametasone and triiodothyronine transcriptional rate and mRNA stability changes in pituitary tumor cells. J Mol Biol 1985, 181: 41-62.
8. Volpato CB, Nunes MT. Role of thyroid hormone in the control of growth hormone gene expression. Braz J Med Biol Res 1994, 27: 1269-72.
9. Volpato CB, Nunes MT. Indirect evidence for a role of the 5′-monodeiodinase on the regulation of GH mRNA levels. Thyroid 1994, 4 (Suppl.): S-86.
10. Cattini PA, Anderson TR, Baxter JD, Mellon P, Eberhardt NL. The human growth hormone gene is negatively regulated by triiodothyronine when transfected into rat pituitary tumor cells. J Biol Chem 1986, 261: 13367-72.
11. Chomczynski P, Soszynski PA, Frohman LA. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J Clin Endocrinol Metab 1993, 77: 281-5.
12. Korytko AI, Cuttler L. Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression. J Endocrinol 1997, 152: R13-7.
13. Miki N, Ono M, Murata Y, et al. Thyroid hormone regulation of gene expression of the pituitary growth hormone-releasing factor receptor. Biochem Biophys Res Commun 1995, 217: 1087-93.
14. Tam SP, Lam KS, Srivastava G. Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism. Endocrinology 1996, 137: 418-24.
15. Kamegai J, Tamura H, Ishii S, Sugihara H, Wakabayashi I. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol 2001, 13: 275-8.
16. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 2001, 142: 2649-59.
17. Burgess JA, Smith BR, Merimee TJ. Growth hormone in thyrotoxicosis: Effect of insulin-induced hypoglycemia. J Clin Endocrinol Metab 1966, 26: 1257-60.
18. Giustina A, Buffoli MG, Bussi AR, Wehrenberg WB. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. Horm Res 1991, 36: 192-5.
19. Giustina A, Schettino M, Bussi AR, et al. Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism. Horm Res 1992, 38: 256-9.
20. Valcavi R, Dieguez C, Zini M, Muruais C, Casanueva F, Portioli I. Influence of hyperthyroidism on growth hormone secretion. Clin Endocrinol 1993, 38: 515-22.
21. Ramos-Dias JC, Yateman M, Camacho-Hübner C, Grossman A, Lengyel AMJ. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Clin Endocrinol 1995, 43: 583-9.
22. Giustina A, Ferrari C, Bodini C, et al. Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism. Acta Endocrinol (Copenh) 1990, 123: 613-8.
23. 3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients. Clin Endocrinol (Oxf) 1999, 51: 461-7.
24. Wu SY, Chopra IJ, Solomon DH, Johnson DE. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J Clin Endocrinol Metab 1978, 47: 1358-62.
25. Bal C, Nair N. The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism. J Nucl Med 1990, 31: 1180-2.
26. Bürgi H, Wimpfheimer C, Burger A, Zaunbauer W, Rosler H, Lemarchand-Béraud T. Changes of circulating thyroxine, triiodothyronine, and reverse triiodothyronine, and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 1976, 43: 1203-10.
27. Kaplan MM, Utiger RD. Iodothyronine metabolism in rat liver homogenates. J Clin Invest 1978, 61: 459-71.
28. St. Germain DL. Dual mechanisms of regulation of type I iodothyronine 5′-deiodinase in the rat kidney, liver and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents. J Clin Invest 1988, 81: 1476-84.
29. Larsen PR, Dick TE, Markovitz BP, Kaplan MM, Gard TG. Inhibition of intrapituitary thyroxine to 3,5,3′-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest 1979, 64: 117-28.
30. Kaplan MM. Thyroxine 5′-monodeiodination in rat anterior pituitary homogenates. Endocrinology 1980, 106: 567-76.
31. Ramos-Dias JC, Pimentel-Filho F, Reis AF, Lengyel AMJ. Different growth hormone (GH) responses to GH-releasing peptide and GH-releasing hormone in hyperthyroidism. J Clin Endocrinol Metab 1996, 81: 1343-6.
32. Vieira JGH, Lombardi MT, Nishida SK. Monoclonal antibody-based immunoenzymometric assay for serum human growth hormone. Braz J Med Biol Res 1990, 23: 293-6.
33. Sharp B, Reed AW, Tamagna EI, Geffner DL, Hershman JM. Treatment of hyperthyroidism with sodium ipodate (Orografin) in addition to propylthiouracil and propranolol. J Clin Endocrinol Metab 1981, 53: 622-5.
34. Escobar-Morreale HF, Obregón MJ, Hernández A, Escobar Del Rey F, Morreale De Escobar G. Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine. Endocrinology 1997, 138: 2559-68.
35. Yeung RTT. Effect of propranolol on plasma growth hormone response in insulin-induced hypoglycemia in thyrotoxic patients. J Clin Endocrinol Metab 1973, 37: 968-71.
36. Valcavi R, Dieguez C, Zini M, et al. Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients. Clin Endocrinol 1991, 35: 141-4.
37. Cheng K, Chan WW, Barreto A Jr, Convey EM, Smith RG. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989, 124: 2791-8.
38. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991, 128: 2027-35.
39. Korbonits M, Grossman AB. Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol Metab 1995, 6: 43-9.
40. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273: 974-7.
41. Smith RG, Pong S-S, Hickey GJ, et al. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 1996, 51: 261-86.